Scheltens P - Search Results

1

Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.

Dubois B, Padovani A, Scheltens P, Rossi A, Dell'Agnello G. Dubois B, et al. Among authors: scheltens p. J Alzheimers Dis. 2016;49(3):617-31. doi: 10.3233/JAD-150692. J Alzheimers Dis. 2016. PMID: 26484931 Free PMC article. Review.

2

Head trauma and Alzheimer's disease.

Nandoe RD, Scheltens P, Eikelenboom P. Nandoe RD, et al. Among authors: scheltens p. J Alzheimers Dis. 2002 Aug;4(4):303-8. doi: 10.3233/jad-2002-4405. J Alzheimers Dis. 2002. PMID: 12446932

3

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Dubois B, et al. Among authors: scheltens p. Lancet Neurol. 2007 Aug;6(8):734-46. doi: 10.1016/S1474-4422(07)70178-3. Lancet Neurol. 2007. PMID: 17616482 Review.

4

Revised research diagnostic criteria for Alzheimer's disease.

Gauthier S, Dubois B, Feldman H, Scheltens P. Gauthier S, et al. Among authors: scheltens p. Lancet Neurol. 2008 Aug;7(8):668-70. doi: 10.1016/S1474-4422(08)70146-7. Lancet Neurol. 2008. PMID: 18635012 No abstract available.

5

CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.

Kester MI, Blankenstein MA, Bouwman FH, van Elk EJ, Scheltens P, van der Flier WM. Kester MI, et al. Among authors: scheltens p. J Alzheimers Dis. 2009;16(3):601-7. doi: 10.3233/JAD-2009-0999. J Alzheimers Dis. 2009. PMID: 19276554

6

Imaging in Alzheimer's disease.

Scheltens P. Scheltens P. Dialogues Clin Neurosci. 2009;11(2):191-9. doi: 10.31887/DCNS.2009.11.2/pscheltens. Dialogues Clin Neurosci. 2009. PMID: 19585954 Free PMC article. Review.

7

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

Mulder C, Verwey NA, van der Flier WM, Bouwman FH, Kok A, van Elk EJ, Scheltens P, Blankenstein MA. Mulder C, et al. Among authors: scheltens p. Clin Chem. 2010 Feb;56(2):248-53. doi: 10.1373/clinchem.2009.130518. Epub 2009 Oct 15. Clin Chem. 2010. PMID: 19833838

8

Early-versus late-onset Alzheimer's disease: more than age alone.

Koedam EL, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YA. Koedam EL, et al. Among authors: scheltens p. J Alzheimers Dis. 2010;19(4):1401-8. doi: 10.3233/JAD-2010-1337. J Alzheimers Dis. 2010. PMID: 20061618

9

BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.

Mulder SD, van der Flier WM, Verheijen JH, Mulder C, Scheltens P, Blankenstein MA, Hack CE, Veerhuis R. Mulder SD, et al. Among authors: scheltens p. J Alzheimers Dis. 2010;20(1):253-60. doi: 10.3233/JAD-2010-1367. J Alzheimers Dis. 2010. PMID: 20164582

10

Can nutrients prevent or delay onset of Alzheimer's disease?

Kamphuis PJ, Scheltens P. Kamphuis PJ, et al. Among authors: scheltens p. J Alzheimers Dis. 2010;20(3):765-75. doi: 10.3233/JAD-2010-091558. J Alzheimers Dis. 2010. PMID: 20182021 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,272 results

Search Page

Filters